Skip to main content

Advertisement

SpringerLink
Log in

Role of urotensin II and its receptor in health and disease

  • Review articles
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

Urotensin II (U-II) is currently the most potent vasoconstrictor identified. This action is brought about via activation of a Gq/11-protein coupled receptor (UT receptor). U-II activation of the UT receptor increases inositol phosphate turnover and intracellular Ca2+. In addition to producing vasoconstriction, dilation and ionotropic effects have also been described. There is considerable variation in the responsiveness of particular vascular beds from the same and different species, including humans. Receptors for U-II are located peripherally on vascular smooth muscle (contractile responses) and endothelial cells (dilatory responses via nitric oxide). In humans, plasma U-II is elevated in heart failure, renal failure, liver disease, and diabetes. Iontophoresis of U-II in healthy volunteers produces vasodilation (of the forearm) while in patients with heart failure or hypertension a constriction is observed. To date there is only one clinical study using a UT receptor antagonist (palosuran) in diabetic patients with macroalbuminuria. This antagonist reduced albumin excretion, probably by increasing renal blood flow. Studies in other disease conditions are eagerly awaited. In summary, the U-II / UT receptor system has clinical potential, and for the anesthesiologist, this novel peptide-receptor system may be of use in the intensive care unit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. D Onan RD Hannan WG Thomas (2004) ArticleTitleUrotensin II: the old kid in town Trends Endocrinol Metab 15 175–182 Occurrence Handle15109617 Occurrence Handle10.1016/j.tem.2004.03.007 Occurrence Handle1:CAS:528:DC%2BD2cXjsVegurg%3D

    Article  PubMed  CAS  Google Scholar 

  2. RS Ames HM Sarau JK Chambers RN Willette NV Aiyar AM Romanic CS Louden JJ Foley CF Sauermelch RW Coatney Z Ao J Disa SD Holmes JM Stadel JD Martin WS Liu GI Glover S Wilson DE McNulty CE Ellis NA Elshourbagy U Shabon JJ Trill DW Hay SA Douglas (1999) ArticleTitleHuman urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 Nature 401 282–286 Occurrence Handle10499587 Occurrence Handle10.1038/45809 Occurrence Handle1:CAS:528:DyaK1MXmt1yku7k%3D

    Article  PubMed  CAS  Google Scholar 

  3. A Stirrat M Gallagher SA Douglas EH Ohlstein C Berry A Kirk M Richardson MR MacLean (2001) ArticleTitlePotent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries Am J Physiol Heart Circ Physiol 280 H925–928 Occurrence Handle11158995 Occurrence Handle1:CAS:528:DC%2BD3MXjtVWks78%3D

    PubMed  CAS  Google Scholar 

  4. FD Russell P Molenaar DM O'Brien (2001) ArticleTitleCardiostimulant effects of urotensin-II in human heart in vitro Br J Pharmacol 132 5–9 Occurrence Handle11156554 Occurrence Handle10.1038/sj.bjp.0703811 Occurrence Handle1:CAS:528:DC%2BD3MXhtFCisLw%3D

    Article  PubMed  CAS  Google Scholar 

  5. M Matsushita M Shichiri T Imai M Iwashina H Tanaka N Takasu Y Hirata (2001) ArticleTitleCo-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues J Hypertens 19 2185–2190 Occurrence Handle11725162 Occurrence Handle10.1097/00004872-200112000-00011 Occurrence Handle1:CAS:528:DC%2BD3MXpt1Cms7k%3D

    Article  PubMed  CAS  Google Scholar 

  6. S Jegou D Cartier C Dubessy BJ Gonzalez D Chatenet H Tostivint E Scalbert J LePrince H Vaudry I Lihrmann (2006) ArticleTitleLocalization of the urotensin II receptor in the rat central nervous system J Comp Neurol 495 21–36 Occurrence Handle16432902 Occurrence Handle10.1002/cne.20845 Occurrence Handle1:CAS:528:DC%2BD28XitFSlurg%3D

    Article  PubMed  CAS  Google Scholar 

  7. AP Davenport JJ Maguire (2000) ArticleTitleUrotensin II: fish neuropeptide catches orphan receptor Trends Pharmacol Sci 21 80–82 Occurrence Handle10689357 Occurrence Handle10.1016/S0165-6147(00)01449-8 Occurrence Handle1:CAS:528:DC%2BD3cXhsFOisbo%3D

    Article  PubMed  CAS  Google Scholar 

  8. KL Ong KS Lam BM Cheung (2005) ArticleTitleUrotensin II: its function in health and its role in disease Cardiovasc Drugs Ther 19 65–75 Occurrence Handle15883758 Occurrence Handle10.1007/s10557-005-6899-x Occurrence Handle1:CAS:528:DC%2BD2MXjvF2mu7c%3D

    Article  PubMed  CAS  Google Scholar 

  9. YC Zhu YZ Zhu PK Moore (2006) ArticleTitleThe role of urotensin II in cardiovascular and renal physiology and diseases Br J Pharmacol 148 884–901 Occurrence Handle16783414 Occurrence Handle10.1038/sj.bjp.0706800 Occurrence Handle1:CAS:528:DC%2BD28XnsFWrtbc%3D

    Article  PubMed  CAS  Google Scholar 

  10. SA Douglas D Dhanak DG Johns (2004) ArticleTitleFrom “gills to pills”: urotensin-II as a regulator of mammalian cardiorenal function Trends Pharmacol Sci 25 76–85 Occurrence Handle15102493 Occurrence Handle10.1016/j.tips.2003.12.005 Occurrence Handle1:CAS:528:DC%2BD2cXhtVOrt78%3D

    Article  PubMed  CAS  Google Scholar 

  11. SA Douglas (2003) ArticleTitleHuman urotensin-II as a novel cardiovascular target: “heart” of the matter or simply a fishy “tail Curr Opin Pharmacol 3 159–167 Occurrence Handle12681238 Occurrence Handle10.1016/S1471-4892(03)00012-2 Occurrence Handle1:CAS:528:DC%2BD3sXis1GltLY%3D

    Article  PubMed  CAS  Google Scholar 

  12. AM Watson CN May (2004) ArticleTitleUrotensin II, a novel peptide in central and peripheral cardiovascular control Peptides 25 1759–1766 Occurrence Handle15476943 Occurrence Handle10.1016/j.peptides.2004.04.016 Occurrence Handle1:CAS:528:DC%2BD2cXotlWgtL8%3D

    Article  PubMed  CAS  Google Scholar 

  13. SA Douglas EH Ohlstein (2000) ArticleTitleHuman urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease Trends Cardiovasc Med 10 229–237 Occurrence Handle11282300 Occurrence Handle10.1016/S1050-1738(00)00069-4 Occurrence Handle1:CAS:528:DC%2BD3MXitF2ktrw%3D

    Article  PubMed  CAS  Google Scholar 

  14. SA Douglas EH Ohlstein (2000) Urotensin receptors D Girdlestone (Eds) The IUPHAR compendium of receptor characterisation and classification IUPHAR Media London 365–372

    Google Scholar 

  15. V Camarda R Guerrini E Kostenis A Rizzi G Calo A Hattenberger M Zucchini S Salvadori D Regoli (2002) ArticleTitleA new ligand for the urotensin II receptor Br J Pharmacol 137 311–314 Occurrence Handle12237249 Occurrence Handle10.1038/sj.bjp.0704895 Occurrence Handle1:CAS:528:DC%2BD38Xns1Ciuro%3D

    Article  PubMed  CAS  Google Scholar 

  16. SA Douglas D Naselsky Z Ao J Disa CL Herold F Lynch NV Aiyar (2004) ArticleTitleIdentification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines Br J Pharmacol 142 921–932 Occurrence Handle15210573 Occurrence Handle10.1038/sj.bjp.0705743 Occurrence Handle1:CAS:528:DC%2BD2cXmtlymtbk%3D

    Article  PubMed  CAS  Google Scholar 

  17. W Song J McDonald V Camarda G Calo R Guerrini E Marzola JP Thompson DJ Rowbotham DG Lambert (2006) ArticleTitleCell and tissue responses of a range of urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity Naunyn Schmiedebergs Arch Pharmacol 373 148–157 Occurrence Handle16596397 Occurrence Handle10.1007/s00210-006-0057-2 Occurrence Handle1:CAS:528:DC%2BD28Xks1els74%3D

    Article  PubMed  CAS  Google Scholar 

  18. CM Filipeanu E Brailoiu S Le Dun NJ Dun (2002) ArticleTitleUrotensin-II regulates intracellular calcium in dissociated rat spinal cord neurons J Neurochem 83 879–884 Occurrence Handle12421360 Occurrence Handle10.1046/j.1471-4159.2002.01196.x Occurrence Handle1:CAS:528:DC%2BD38XovFOisLs%3D

    Article  PubMed  CAS  Google Scholar 

  19. M Mori T Sugo M Abe Y Shimomura M Kurihara C Kitada K Kikuchi Y Shintani T Kurokawa H Onda O Nishimura M Fujino (1999) ArticleTitleUrotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14) Biochem Biophys Res Commun 265 123–129 Occurrence Handle10548501 Occurrence Handle10.1006/bbrc.1999.1640 Occurrence Handle1:CAS:528:DyaK1MXntVCms7s%3D

    Article  PubMed  CAS  Google Scholar 

  20. Y Coulouarn I Lihrmann S Jegou Y Anouar H Tostivint JC Beauvillain JM Conlon HA Bern H Vaudry (1998) ArticleTitleCloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord Proc Natl Acad Sci USA 95 15803–15808 Occurrence Handle9861051 Occurrence Handle10.1073/pnas.95.26.15803 Occurrence Handle1:CAS:528:DyaK1MXhvFensw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  21. HA Bern D Pearson BA Larson RS Nishioka (1985) ArticleTitleNeurohormones from fish tails: the caudal neurosecretory system. I. “Urophysiology” and the caudal neurosecretory system of fishes Recent Prog Horm Res 41 533–552 Occurrence Handle2864726 Occurrence Handle1:CAS:528:DyaL2MXlslGltLY%3D

    PubMed  CAS  Google Scholar 

  22. WA Kinney HR Almond SuffixJr J Qi CE Smith RJ Santulli L de Garavilla P Andrade-Gordon DS Cho AM Everson MA Feinstein PA Leung BE Maryanoff (2002) ArticleTitleStructure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model Angew Chem Int Ed Engl 41 2940–2944 Occurrence Handle12203418 Occurrence Handle10.1002/1521-3773(20020816)41:16<2940::AID-ANIE2940>3.0.CO;2-M Occurrence Handle1:CAS:528:DC%2BD38XmslSrsbw%3D

    Article  PubMed  CAS  Google Scholar 

  23. M Mori M Fujino (2004) ArticleTitleUrotensin II-related peptide, the endogenous ligand for the urotensin II receptor in the rat brain Peptides 25 1815–1818 Occurrence Handle15476951 Occurrence Handle10.1016/j.peptides.2004.06.025 Occurrence Handle1:CAS:528:DC%2BD2cXotlWgtLc%3D

    Article  PubMed  CAS  Google Scholar 

  24. T Sugo Y Murakami Y Shimomura M Harada M Abe Y Ishibashi C Kitada N Miyajima N Suzuki M Mori M Fujino (2003) ArticleTitleIdentification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain Biochem Biophys Res Commun 310 860–868 Occurrence Handle14550283 Occurrence Handle10.1016/j.bbrc.2003.09.102 Occurrence Handle1:CAS:528:DC%2BD3sXnvVyltbg%3D

    Article  PubMed  CAS  Google Scholar 

  25. S Flohr M Kurz E Kostenis A Brkovich A Fournier T Klabunde (2002) ArticleTitleIdentification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II J Med Chem 45 1799–1805 Occurrence Handle11960491 Occurrence Handle10.1021/jm0111043 Occurrence Handle1:CAS:528:DC%2BD38XitVOjurs%3D

    Article  PubMed  CAS  Google Scholar 

  26. V Camarda M Spagnol W Song R Vergura AL Roth JP Thompson DJ Rowbotham R Guerrini E Marzola S Salvadori P Cavanni D Regoli SA Douglas DG Lambert G Calo (2006) ArticleTitleIn vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5),DTrp(7),Dab(8)]urotensin II(4-11) (UFP-803) Br J Pharmacol 147 92–100 Occurrence Handle16273120 Occurrence Handle10.1038/sj.bjp.0706438 Occurrence Handle1:CAS:528:DC%2BD28XitVSltA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  27. R Patacchini P Santicioli S Giuliani P Grieco E Novellino P Rovero CA Maggi (2003) ArticleTitleUrantide: an ultrapotent urotensin II antagonist peptide in the rat aorta Br J Pharmacol 140 1155–1158 Occurrence Handle14645137 Occurrence Handle10.1038/sj.bjp.0705555 Occurrence Handle1:CAS:528:DC%2BD2cXpvV2ntQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  28. V Camarda W Song E Marzola M Spagnol R Guerrini S Salvadori D Regoli JP Thompson DJ Rowbotham DJ Behm SA Douglas G Calo DG Lambert (2004) ArticleTitleUrantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors Eur J Pharmacol 498 83–86 Occurrence Handle15363979 Occurrence Handle10.1016/j.ejphar.2004.07.089 Occurrence Handle1:CAS:528:DC%2BD2cXnsFGks78%3D

    Article  PubMed  CAS  Google Scholar 

  29. M Clozel C Binkert M Birker-Robaczewska C Boukhadra SS Ding W Fischli P Hess B Mathys K Morrison C Muller C Muller O Nayler C Qiu M Rey MW Scherz J Velker T Weller JF Xi P Ziltener (2004) ArticleTitlePharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System J Pharmacol Exp Ther 311 204–212 Occurrence Handle15146030 Occurrence Handle10.1124/jpet.104.068320 Occurrence Handle1:CAS:528:DC%2BD2cXosVKrt70%3D

    Article  PubMed  CAS  Google Scholar 

  30. GE Croston R Olsson EA Currier ES Burstein D Weiner N Nash D Severance SG Allenmark L Thunberg JN Ma N Mohell B O'Dowd MR Brann U Hacksell (2002) ArticleTitleDiscovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chlorophenyl)-3-(2-(dimethylamino)ethyl)isochroman-1-one (AC-7954) J Med Chem 45 4950–4953 Occurrence Handle12408704 Occurrence Handle10.1021/jm025551+ Occurrence Handle1:CAS:528:DC%2BD38Xns1GhsL0%3D

    Article  PubMed  CAS  Google Scholar 

  31. SA Douglas DJ Behm NV Aiyar D Naselsky J Disa DP Brooks EH Ohlstein JG Gleason HM Sarau JJ Foley PT Buckley DB Schmidt WE Wixted K Widdowson G Riley J Jin TF Gallagher SJ Schmidt L Ridgers LT Christmann RM Keenan SD Knight D Dhanak (2005) ArticleTitleNonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375. Br J Pharmacol 145 620–635 Occurrence Handle1:CAS:528:DC%2BD2MXlslWhsb4%3D

    CAS  Google Scholar 

  32. A Carotenuto P Grieco P Rovero E Novellino (2006) ArticleTitleUrotensin-II receptor antagonists Curr Med Chem 13 267–275 Occurrence Handle16475936 Occurrence Handle10.2174/092986706775476061 Occurrence Handle1:CAS:528:DC%2BD28XhtVequrk%3D

    Article  PubMed  CAS  Google Scholar 

  33. A Gibson S Conyers HA Bern (1988) ArticleTitleThe influence of urotensin II on calcium flux in rat aorta J Pharm Pharmacol 40 893–895 Occurrence Handle2907588 Occurrence Handle1:CAS:528:DyaL1MXhvFSgtg%3D%3D

    PubMed  CAS  Google Scholar 

  34. V Camarda A Rizzi G Calo G Gendron SI Perron E Kostenis P Zamboni F Mascoli D Regoli (2002) ArticleTitleEffects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents Naunyn Schmiedebergs Arch Pharmacol 365 141–149 Occurrence Handle11819032 Occurrence Handle10.1007/s00210-001-0503-0 Occurrence Handle1:CAS:528:DC%2BD38Xls1CqsA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  35. O Saetrum Opgaard H Nothacker FJ Ehlert DN Krause (2000) ArticleTitleHuman urotensin II mediates vasoconstriction via an increase in inositol phosphates Eur J Pharmacol 406 265–271 Occurrence Handle11020490 Occurrence Handle10.1016/S0014-2999(00)00672-5 Occurrence Handle1:STN:280:DC%2BD3M%2Fls1WgsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  36. JJ Maguire AP Davenport (2002) ArticleTitleIs urotensin-II the new endothelin? Br J Pharmacol 137 579–588 Occurrence Handle12381671 Occurrence Handle10.1038/sj.bjp.0704924 Occurrence Handle1:CAS:528:DC%2BD38XosF2htrg%3D

    Article  PubMed  CAS  Google Scholar 

  37. M Batuwangala J McDonald G Calo LL Ng DG Lambert (2006) ArticleTitleCharacterization of native urotensin II receptors expressed in SJCRH30 rhabdomyosarcoma cells Br J Anaesth 97 440

    Google Scholar 

  38. D Onan L Pipolo E Yang RD Hannan WG Thomas (2004) ArticleTitleUrotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinases Mol Endocrinol 18 2344–2354 Occurrence Handle15205471 Occurrence Handle10.1210/me.2003-0309 Occurrence Handle1:CAS:528:DC%2BD2cXnsVKgtbk%3D

    Article  PubMed  CAS  Google Scholar 

  39. PH Sugden A Clerk (1998) ArticleTitleCellular mechanisms of cardiac hypertrophy J Mol Med 76 725–746 Occurrence Handle9826118 Occurrence Handle10.1007/s001090050275 Occurrence Handle1:STN:280:DyaK1M%2FktFCqsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  40. A Clerk PH Sugden (1999) ArticleTitleActivation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists Am J Cardiol 83 64H–69H Occurrence Handle10750590 Occurrence Handle10.1016/S0002-9149(99)00261-1 Occurrence Handle1:CAS:528:DyaK1MXks1Gltr0%3D

    Article  PubMed  CAS  Google Scholar 

  41. P Ziltener C Mueller B Haenig MW Scherz O Nayler (2002) ArticleTitleUrotensin II mediates ERK1/2 phosphorylation and proliferation in GPR14-transfected cell lines J Recept Signal Transduct Res 22 155–168 Occurrence Handle12503613 Occurrence Handle10.1081/RRS-120014593 Occurrence Handle1:CAS:528:DC%2BD38Xps1ejs7w%3D

    Article  PubMed  CAS  Google Scholar 

  42. TF Luscher (1991) ArticleTitleEndothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system Eur Heart J 12 IssueIDSuppl E 2–11 Occurrence Handle1790780

    PubMed  Google Scholar 

  43. Moncada S, Higgs EA (2006) Nitric oxide and the vascular endothelium. Handb Exp Pharmacol 213–254

  44. V Camarda A Rizzi G Calo G Gendron SI Perron E Kostenis P Zamboni F Mascoli D Regoli (2002) ArticleTitleEffects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents Naunyn Schmiedebergs Arch Pharmacol 365 141–149 Occurrence Handle11819032 Occurrence Handle10.1007/s00210-001-0503-0 Occurrence Handle1:CAS:528:DC%2BD38Xls1CqsA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  45. SA Douglas AC Sulpizio V Piercy HM Sarau RS Ames NV Aiyar EH Ohlstein RN Willette (2000) ArticleTitleDifferential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey Br J Pharmacol 131 1262–1274 Occurrence Handle11090097 Occurrence Handle10.1038/sj.bjp.0703690 Occurrence Handle1:CAS:528:DC%2BD3cXovFygt7g%3D

    Article  PubMed  CAS  Google Scholar 

  46. H Itoh D McMaster K Lederis (1988) ArticleTitleFunctional receptors for fish neuropeptide urotensin II in major rat arteries Eur J Pharmacol 149 61–66 Occurrence Handle3396626 Occurrence Handle10.1016/0014-2999(88)90042-8 Occurrence Handle1:STN:280:DyaL1c3otlyiuw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  47. A Ishihata M Sakai Y Katano (2006) ArticleTitleVascular contractile effect of urotensin II in young and aged rats: influence of aging and contribution of endothelial nitric oxide Peptides 27 80–86 Occurrence Handle16159683 Occurrence Handle10.1016/j.peptides.2005.07.012 Occurrence Handle1:CAS:528:DC%2BD28Xktl2ntQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  48. FE Bottrill SA Douglas CR Hiley R White (2000) ArticleTitleHuman urotensin-II is an endothelium-dependent vasodilator in rat small arteries Br J Pharmacol 130 1865–1870 Occurrence Handle10952676 Occurrence Handle10.1038/sj.bjp.0703513 Occurrence Handle1:CAS:528:DC%2BD3cXmtFenu7c%3D

    Article  PubMed  CAS  Google Scholar 

  49. MR MacLean D Alexander A Stirrat M Gallagher SA Douglas EH Ohlstein I Morecroft K Polland (2000) ArticleTitleContractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat Br J Pharmacol 130 201–204 Occurrence Handle10807654 Occurrence Handle10.1038/sj.bjp.0703314 Occurrence Handle1:CAS:528:DC%2BD3cXjsl2mtLg%3D

    Article  PubMed  CAS  Google Scholar 

  50. I Muramatsu M Fujiwara H Hidaka H Akutagawa (1979) Pharmacological analysis of urotensin-induced contraction and relaxation in isolated rabbit aortas K Yamamoto (Eds) The caudal neurosecretory system of fishes (16th Gunma Symposium in Endocrinology) Gunma University Maebashi, Japan 39–47

    Google Scholar 

  51. SM Gardiner JE March PA Kemp AP Davenport T Bennett (2001) ArticleTitleDepressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats Br J Pharmacol 132 1625–1629 Occurrence Handle11309232 Occurrence Handle10.1038/sj.bjp.0704051 Occurrence Handle1:CAS:528:DC%2BD3MXjt1arsL0%3D

    Article  PubMed  CAS  Google Scholar 

  52. SM Gardiner JE March PA Kemp JJ Maguire RE Kuc AP Davenport T Bennett (2006) ArticleTitleRegional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation Br J Pharmacol 147 612–621 Occurrence Handle16314853 Occurrence Handle10.1038/sj.bjp.0706503 Occurrence Handle1:CAS:528:DC%2BD28XisFOntrw%3D

    Article  PubMed  CAS  Google Scholar 

  53. GA Gray MR Jones I Sharif (2001) ArticleTitleHuman urotensin II increases coronary perfusion pressure in the isolated rat heart: potentiation by nitric oxide synthase and cyclooxygenase inhibition Life Sci 69 175–180 Occurrence Handle11441907 Occurrence Handle10.1016/S0024-3205(01)01101-8 Occurrence Handle1:CAS:528:DC%2BD3MXkt1Cgtbk%3D

    Article  PubMed  CAS  Google Scholar 

  54. DJ Behm SM Harrison Z Ao K Maniscalco SJ Pickering EV Grau TN Woods RW Coatney CP Doe RN Willette DG Johns SA Douglas (2003) ArticleTitleDeletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice Br J Pharmacol 139 464–472 Occurrence Handle12770952 Occurrence Handle10.1038/sj.bjp.0705254 Occurrence Handle1:CAS:528:DC%2BD3sXkvFClt7Y%3D

    Article  PubMed  CAS  Google Scholar 

  55. ZJ Wang LB Shi ZW Xiong LF Zhang L Meng DF Bu CS Tang WH Ding (2006) ArticleTitleAlteration of vascular urotensin II receptor in mice with apolipoprotein E gene knockout Peptides 27 858–863 Occurrence Handle16325305 Occurrence Handle10.1016/j.peptides.2005.08.028 Occurrence Handle1:CAS:528:DC%2BD28XjtFWqs7g%3D

    Article  PubMed  CAS  Google Scholar 

  56. Y Coulouarn C Fernex S Jegou CE Henderson H Vaudry I Lihrmann (2001) ArticleTitleSpecific expression of the urotensin II gene in sacral motoneurons of developing rat spinal cord Mech Dev 101 187–190 Occurrence Handle11231072 Occurrence Handle10.1016/S0925-4773(00)00548-7 Occurrence Handle1:CAS:528:DC%2BD3MXhsFShtbw%3D

    Article  PubMed  CAS  Google Scholar 

  57. SL Dun GC Brailoiu J Yang JK Chang NJ Dun (2001) ArticleTitleUrotensin II-immunoreactivity in the brainstem and spinal cord of the rat Neurosci Lett 305 9–12 Occurrence Handle11356295 Occurrence Handle10.1016/S0304-3940(01)01804-3 Occurrence Handle1:CAS:528:DC%2BD3MXjsFeisbo%3D

    Article  PubMed  CAS  Google Scholar 

  58. Y Lin T Tsuchihashi K Matsumura I Abe M Iida (2003) ArticleTitleCentral cardiovascular action of urotensin II in conscious rats J Hypertens 21 159–165 Occurrence Handle12544448 Occurrence Handle10.1097/00004872-200301000-00026 Occurrence Handle1:CAS:528:DC%2BD3sXlsV2iuw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  59. AM Watson GW Lambert KJ Smith CN May (2003) ArticleTitleUrotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions Hypertension 42 373–379 Occurrence Handle12885791 Occurrence Handle10.1161/01.HYP.0000084633.85427.E6 Occurrence Handle1:CAS:528:DC%2BD3sXmslSjurk%3D

    Article  PubMed  CAS  Google Scholar 

  60. JJ Maguire RE Kuc AP Davenport (2000) ArticleTitleOrphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 131 441–446 Occurrence Handle1:CAS:528:DC%2BD3cXnsVygt7g%3D

    CAS  Google Scholar 

  61. K Totsune K Takahashi Z Arihara M Sone S Ito O Murakami (2003) ArticleTitleIncreased plasma urotensin II levels in patients with diabetes mellitus Clin Sci (Lond) 104 1–5 Occurrence Handle1:CAS:528:DC%2BD3sXitVOruw%3D%3D Occurrence Handle10.1042/CS20020271

    Article  CAS  Google Scholar 

  62. J Heller M Schepke M Neef R Woitas C Rabe T Sauerbruch (2002) ArticleTitleIncreased urotensin II plasma levels in patients with cirrhosis and portal hypertension J Hepatol 37 767–772 Occurrence Handle12445417 Occurrence Handle10.1016/S0168-8278(02)00295-7 Occurrence Handle1:CAS:528:DC%2BD38XoslCjtLc%3D

    Article  PubMed  CAS  Google Scholar 

  63. N Aiyar B Guida Z Ao J Disa D Naselsky DJ Behm JL Su FC Kull SA Douglas SuffixJr (2004) ArticleTitleDifferential levels of “urotensin-II-like” activity determined by radio-receptor and radioimmuno-assays Peptides 25 1339–1347 Occurrence Handle15350702 Occurrence Handle10.1016/j.peptides.2004.05.015 Occurrence Handle1:CAS:528:DC%2BD2cXntlelsr0%3D

    Article  PubMed  CAS  Google Scholar 

  64. SA Douglas L Tayara EH Ohlstein N Halawa A Giaid (2002) ArticleTitleCongestive heart failure and expression of myocardial urotensin II Lancet 359 1990–1997 Occurrence Handle12076554 Occurrence Handle10.1016/S0140-6736(02)08831-1 Occurrence Handle1:CAS:528:DC%2BD38XksFKkt7o%3D

    Article  PubMed  CAS  Google Scholar 

  65. M Lim S Honisett CD Sparkes P Komesaroff A Kompa H Krum (2004) ArticleTitleDifferential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure Circulation 109 1212–1214 Occurrence Handle15007012 Occurrence Handle10.1161/01.CIR.0000121326.69153.98 Occurrence Handle1:CAS:528:DC%2BD2cXhvFakt70%3D

    Article  PubMed  CAS  Google Scholar 

  66. JP Thompson P Watt S Sanghavi JW Strupish DG Lambert (2003) ArticleTitleA comparison of cerebrospinal fluid and plasma urotensin II concentrations in normotensive and hypertensive patients undergoing urological surgery during spinal anesthesia: a pilot study Anesth Analg 97 1501–1503 Occurrence Handle14570674 Occurrence Handle10.1213/01.ANE.0000086723.97421.BC Occurrence Handle1:CAS:528:DC%2BD3sXptlCisrg%3D

    Article  PubMed  CAS  Google Scholar 

  67. E Cowley JP Thompson P Sharpe J Waugh N Ali DG Lambert (2005) ArticleTitleEffects of pre-eclampsia on maternal plasma, cerebrospinal fluid, and umbilical cord urotensin II concentrations: a pilot study Br J Anaesth 95 495–499 Occurrence Handle16126783 Occurrence Handle10.1093/bja/aei222 Occurrence Handle1:CAS:528:DC%2BD2MXpvFGqtLk%3D

    Article  PubMed  CAS  Google Scholar 

  68. O Balat F Aksoy I Kutlar MG Ugur H Iyikosker A Balat R Anarat (2005) ArticleTitleIncreased plasma levels of urotensin-II in preeclampsia-eclampsia: a new mediator in pathogenesis? Eur J Obstet Gynecol Reprod Biol 120 33–38 Occurrence Handle15866083 Occurrence Handle10.1016/j.ejogrb.2004.07.029 Occurrence Handle1:CAS:528:DC%2BD2MXjslKgsro%3D

    Article  PubMed  CAS  Google Scholar 

  69. B Sondermeijer A Kompa P Komesaroff H Krum (2005) ArticleTitleEffect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension Am J Hypertens 18 1195–1199 Occurrence Handle16182109 Occurrence Handle10.1016/j.amjhyper.2005.03.748 Occurrence Handle1:CAS:528:DC%2BD2MXhtVegurbI

    Article  PubMed  CAS  Google Scholar 

  70. K Totsune K Takahashi Z Arihara M Sone F Satoh S Ito Y Kimura H Sasano O Murakami (2001) ArticleTitleRole of urotensin II in patients on dialysis Lancet 358 810–811 Occurrence Handle11564491 Occurrence Handle10.1016/S0140-6736(01)06002-0 Occurrence Handle1:CAS:528:DC%2BD3MXmvVKmsbg%3D

    Article  PubMed  CAS  Google Scholar 

  71. K Totsune K Takahashi Z Arihara M Sone O Murakami S Ito M Kikuya T Ohkubo J Hashimoto Y Imai (2004) ArticleTitleElevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy Peptides 25 1809–1814 Occurrence Handle15476950 Occurrence Handle10.1016/j.peptides.2004.06.024 Occurrence Handle1:CAS:528:DC%2BD2cXotlWgtLY%3D

    Article  PubMed  CAS  Google Scholar 

  72. Z Wenyi S Suzuki M Hirai Y Hinokio Y Tanizawa A Matsutani J Satoh Y Oka (2003) ArticleTitleRole of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects Diabetologia 46 972–976 Occurrence Handle12830381 Occurrence Handle10.1007/s00125-003-1145-1 Occurrence Handle1:CAS:528:DC%2BD3sXls1yns7o%3D

    Article  PubMed  CAS  Google Scholar 

  73. S Suzuki Z Wenyi M Hirai Y Hinokio C Suzuki T Yamada S Yoshizumi M Suzuki Y Tanizawa A Matsutani Y Oka (2004) ArticleTitleGenetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in Japanese Peptides 25 1803–1808 Occurrence Handle15476949 Occurrence Handle10.1016/j.peptides.2004.03.030 Occurrence Handle1:CAS:528:DC%2BD2cXotlWgtLk%3D

    Article  PubMed  CAS  Google Scholar 

  74. KL Ong LY Wong YB Man RY Leung YQ Song KS Lam BM Cheung (2006) ArticleTitleHaplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance Peptides 27 1659–1667 Occurrence Handle16597476 Occurrence Handle10.1016/j.peptides.2006.02.008 Occurrence Handle1:CAS:528:DC%2BD28XlsFCjurc%3D

    Article  PubMed  CAS  Google Scholar 

  75. IB Wilkinson JT Affolter SL de Haas MP Pellegrini J Boyd MJ Winter RJ Balment DJ Webb (2002) ArticleTitleHigh plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man Cardiovasc Res 53 341–347 Occurrence Handle11827684 Occurrence Handle10.1016/S0008-6363(01)00485-0 Occurrence Handle1:CAS:528:DC%2BD38XhtVKks7s%3D

    Article  PubMed  CAS  Google Scholar 

  76. JT Affolter DE Newby IB Wilkinson MJ Winter RJ Balment DJ Webb (2002) ArticleTitleNo effect on central or peripheral blood pressure of systemic urotensin II infusion in humans Br J Clin Pharmacol 54 617–621 Occurrence Handle12492609 Occurrence Handle10.1046/j.1365-2125.2002.t01-1-01704.x Occurrence Handle1:CAS:528:DC%2BD3sXnvVansA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  77. M Clozel P Hess C Qiu SS Ding M Rey (2006) ArticleTitleThe urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats J Pharmacol Exp Ther 316 1115–1121 Occurrence Handle16267137 Occurrence Handle10.1124/jpet.105.094821 Occurrence Handle1:CAS:528:DC%2BD28Xit1Sgsro%3D

    Article  PubMed  CAS  Google Scholar 

  78. PN Sidharta FD Wagner H Bohnemeier A Jungnik A Halabi S Krahenbuhl H Chadha-Boreham J Dingemanse (2006) ArticleTitlePharmacodynamics and pharmacokinetics of the urotensin II receptor antagonist palosuran in macroalbuminuric, diabetic patients Clin Pharmacol Ther 80 246–256 Occurrence Handle16952491 Occurrence Handle10.1016/j.clpt.2006.05.013 Occurrence Handle1:CAS:528:DC%2BD28XptFCgu7g%3D

    Article  PubMed  CAS  Google Scholar 

  79. P Grieco A Carotenuto P Campiglia E Zampelli R Patacchini CA Maggi E Novellino P Rovero (2002) ArticleTitleA new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulfide bridge J Med Chem 45 4391–4394 Occurrence Handle12238917 Occurrence Handle10.1021/jm025549i Occurrence Handle1:CAS:528:DC%2BD38Xms1CksbY%3D

    Article  PubMed  CAS  Google Scholar 

  80. DJ Behm G Stankus CP Doe RN Willette HM Sarau JJ Foley DB Schmidt P Nuthulaganti JA Fornwald RS Ames DG Lambert G Calo V Camarda NV Aiyar SA Douglas (2006) ArticleTitleThe peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems Br J Pharmacol 148 173–190 Occurrence Handle16547525 Occurrence Handle10.1038/sj.bjp.0706716 Occurrence Handle1:CAS:528:DC%2BD28XksFSgurk%3D

    Article  PubMed  CAS  Google Scholar 

  81. LL Ng I Loke RJ O'Brien IB Squire JE Davies (2002) ArticleTitlePlasma urotensin in human systolic heart failure Circulation 106 2877–2880 Occurrence Handle12460864 Occurrence Handle10.1161/01.CIR.0000044388.19119.02 Occurrence Handle1:CAS:528:DC%2BD38XovVelt7c%3D

    Article  PubMed  CAS  Google Scholar 

  82. SQ Khan SS Bhandari P Quinn JE Davies LL Ng (2007) ArticleTitleUrotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans Int J Cardiol 117 323–328 Occurrence Handle16887216 Occurrence Handle10.1016/j.ijcard.2006.05.016

    Article  PubMed  Google Scholar 

  83. T Dschietzig C Bartsch R Pregla HR Zurbrugg FP Armbruster C Richter M Laule E Romeyke C Neubert W Voelter G Baumann K Stangl (2002) ArticleTitlePlasma levels and cardiovascular gene expression of urotensin-II in human heart failure Regul Pept 110 33–38 Occurrence Handle12468107 Occurrence Handle10.1016/S0167-0115(02)00158-1 Occurrence Handle1:CAS:528:DC%2BD38XptFelt74%3D

    Article  PubMed  CAS  Google Scholar 

  84. P Zhong ZL Li HC Wu CS Tang Q Lu (2003) ArticleTitleClinical study of changes of urotensin II in patients with congestive heart failure (in Chinese) Di Yi Jun Yi Da Xue Xue Bao (Academic journal of the first medical college of PLA) 23 121–123

    Google Scholar 

  85. FD Russell D Meyers AJ Galbraith N Bett I Toth P Kearns P Molenaar (2003) ArticleTitleElevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure Am J Physiol Heart Circ Physiol 285 H1576–1581 Occurrence Handle12791592 Occurrence Handle1:CAS:528:DC%2BD3sXosVKjt7c%3D

    PubMed  CAS  Google Scholar 

  86. SH Fang ZL Li HC Wu CS Tang Q Lu HC Liu QN Yan (2004) ArticleTitleClinical study of plasma urotensin II in patients with coronary heart disease (in Chinese) Di Yi Jun Yi Da Xue Xue Bao (Academic journal of the first medical college of PLA) 24 563–565 Occurrence Handle1:CAS:528:DC%2BD2cXlt1Ciu7k%3D

    CAS  Google Scholar 

  87. S Kruger J Graf D Kunz T Stickel MW Merx P Hanrath U Janssens (2005) ArticleTitleUrotensin II in patients with chronic heart failure Eur J Heart Fail 7 475–478 Occurrence Handle15921782 Occurrence Handle10.1016/S1388-9842(03)00106-5 Occurrence Handle1:CAS:528:DC%2BD2MXks1emtL4%3D

    Article  PubMed  CAS  Google Scholar 

  88. D Gruson MF Rousseau SA Ahn F van Linden JM Ketelslegers (2005) ArticleTitleCirculating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markers Peptides 27 1527–1531 Occurrence Handle16364499 Occurrence Handle10.1016/j.peptides.2005.11.019 Occurrence Handle1:CAS:528:DC%2BD28XltFOnsro%3D

    Article  PubMed  CAS  Google Scholar 

  89. D Joyal T Huynh N Aiyar B Guida S Douglas A Giaid (2006) ArticleTitleUrotensin-II levels in acute coronary syndromes Int J Cardiol 108 31–35 Occurrence Handle16516696 Occurrence Handle10.1016/j.ijcard.2005.04.001

    Article  PubMed  Google Scholar 

  90. M Heringlake T Kox O Uzun B Will L Bahlmann S Klaus S Eleftheriadis FP Armbruster N Franz E Kraatz (2004) ArticleTitleThe relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease Regul Pept 121 129–136 Occurrence Handle15256283 Occurrence Handle10.1016/j.regpep.2004.04.012 Occurrence Handle1:CAS:528:DC%2BD2cXlsl2jsLw%3D

    Article  PubMed  CAS  Google Scholar 

  91. H Lapp G Boerrigter LC Costello-Boerrigter K Jaekel T Scheffold I Krakau M Schramm H Guelker J-P Stasch (2004) ArticleTitleElevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy Int J Cardiol 94 93–97 Occurrence Handle14996481 Occurrence Handle10.1016/j.ijcard.2003.05.008

    Article  PubMed  Google Scholar 

  92. AM Richards MG Nicholls JG Lainchbury S Fisher TG Yandle (2002) ArticleTitlePlasma urotensin II in heart failure Lancet 360 545–546 Occurrence Handle12241661 Occurrence Handle10.1016/S0140-6736(02)09709-X Occurrence Handle1:CAS:528:DC%2BD38XmtlelsrY%3D

    Article  PubMed  CAS  Google Scholar 

  93. CM Simpson DJ Penny CF Stocker LS Shekerdemian (2006) ArticleTitleUrotensin II is raised in children with congenital heart disease Heart 92 983–984 Occurrence Handle16308415 Occurrence Handle10.1136/hrt.2005.074039 Occurrence Handle1:CAS:528:DC%2BD28Xntl2ltLk%3D

    Article  PubMed  CAS  Google Scholar 

  94. BM Cheung R Leung YB Man LY Wong (2004) ArticleTitlePlasma concentration of urotensin II is raised in hypertension J Hypertens 22 1341–1344 Occurrence Handle15201550 Occurrence Handle10.1097/01.hjh.0000125452.28861.f1 Occurrence Handle1:CAS:528:DC%2BD2cXkvVGisr4%3D

    Article  PubMed  CAS  Google Scholar 

  95. A Balat IH Pakir F Gok R Anarat S Sahinoz (2005) ArticleTitleUrotensin-II levels in children with minimal change nephrotic syndrome Pediatr Nephrol 20 42–45 Occurrence Handle15602665 Occurrence Handle10.1007/s00467-004-1716-5

    Article  PubMed  Google Scholar 

  96. F Mallamaci S Cutrupi P Pizzini G Tripepi C Zoccali (2005) ArticleTitleUrotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides J Nephrol 18 727–732 Occurrence Handle16358231 Occurrence Handle1:CAS:528:DC%2BD28XhsFGmsbs%3D

    PubMed  CAS  Google Scholar 

  97. C Zoccali F Mallamaci G Tripepi S Cutrupi P Pizzini L Malatino (2006) ArticleTitleUrotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease Kidney Int 69 1253–1258 Occurrence Handle16508659 Occurrence Handle10.1038/sj.ki.5000114 Occurrence Handle1:CAS:528:DC%2BD28XivFOmsb8%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Sciences, Pharmacology and Therapeutics Group, Division of Anaesthesia, Critical Care and Pain Management, University of Leicester, LRI, Leicester, LE1 5WW, UK

    John McDonald, Madura Batuwangala & David G. Lambert

Authors
  1. John McDonald
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Madura Batuwangala
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David G. Lambert
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

McDonald, J., Batuwangala, M. & Lambert, D. Role of urotensin II and its receptor in health and disease. J Anesth 21, 378–389 (2007). https://doi.org/10.1007/s00540-007-0524-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-007-0524-z

Key words

Search

Navigation